Krebs Biochemicals & Industr Q2 Results
- BSE: 524518
- NSE: KREBSBIO
- ISIN: INE268B01013
- Sector: Biotechnology & Drugs
BSE
98.53
15.81 (19.11%)
15.81 (19.11%)Volume56.77 K
Updated: Mon 25 Nov, 2024 | 15:47:55
NSE
98.7616.46 (20.00%)
16.46 (20.00%)Volume1.01 L
Updated: Mon 25 Nov, 2024 | 15:27:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹12.86 Cr.(-0.26%)
- Operating Profit₹-4.42 Cr.(13.79%)
- Profit After Tax₹-5.76 Cr.(11.40%)
- Operating Margin-34.40%(96.15%)
Note: Comparison is on YoY basis
Quarterly - Krebs Biochemicals & Industr Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 12.86 | 10.58 | -% | 14.89 | -% |
| Selling/ General/ Admin Expenses Total | 4.39 | 4.06 | -% | 4.09 | -% |
| Depreciation/ Amortization | 1.71 | 1.65 | -% | 1.71 | -% |
| Other Operating Expenses Total | 8.75 | 8.77 | -% | 9.65 | -% |
| Total Operating Expense | 17.28 | 14.85 | -% | 17.50 | -% |
| Operating Income | -4.42 | -4.27 | -% | -2.61 | -% |
| Net Income Before Taxes | -5.76 | -5.33 | -% | -3.57 | -% |
| Net Income | -5.76 | -5.33 | -% | -3.57 | -% |
| Diluted Normalized EPS | -2.67 | -2.47 | -% | -1.66 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST